Bloodstream infections caused by qnr-positive Enterobacteriaceae: Clinical and microbiologic characteristics and outcomes

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 1, 2010, Pages 70-77

  Chong, Yong Pil ^a,b   Choi, Sang Ho ^a,b   Kim, Eun Sil ^a,b   Song, Eun Hee ^a,b   Lee, Eun Jung ^a,b   Park, Ki Ho ^a,b   Cho, Oh Hyun ^a,b   Kim, Sung Han ^a,b   Lee, Sang Oh ^a,b   Kim, Mi Na ^a   Jeong, Jin Yong ^a,b   Woo, Jun Hee ^a,b   Kim, Yang Soo ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

Bacteremia; Enterobacter spp.; Klebsiella pneumoniae; Qnr; Quinolone

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFEPIME; CEPHALOSPORIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; ENTEROBACTER; ENTEROBACTERIACEAE; FEMALE; GENE SEQUENCE; HEMATOLOGIC MALIGNANCY; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGICAL EXAMINATION; MORTALITY; MULTIVARIATE ANALYSIS; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL PROTEINS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; QUINOLONES; SEQUENCE ANALYSIS, DNA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951499484     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.12.003     Document Type: Article

References (26)

1. Charlson M., Pompei P., Ales K., MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 1987, 40:373-383.
2. Choi S.H., Lee J.E., Park S.J., Lee S.O., Jeong J.Y., Kim M.N., Woo J.H., Kim Y.S. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC β-lactamase: implications for antibiotic use. Antimicrob. Agents Chemother. 2008, 52:995-1000.
3. Chow J.W., Fine M.J., Shlaes D.M., Quinn J.P., Hooper D.C., Johnson M.P., Ramphal R., Wagener M.M., Miyashiro D.K., Yu V.L. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 1991, 115:585-590.
4. Friedman N., Kaye K., Stout J., McGarry S., Trivette S., Briggs J., Lamm W., Clark C., MacFarquhar J., Walton A., Reller L., Sexton D. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 2002, 137:791-797.
5. Garner J., Jarvis W., Emori T., Horan T., Hughes J. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control 1988, 16:128-140.
6. Garnier F., Raked N., Gassama A., Denis F., Ploy M.C. Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar. Antimicrob. Agents Chemother. 2006, 50:3200-3202.
7. Ho P., Shek R., Chow K., Duan R., Mak G., Lai E., Yam W., Tsang K., Lai W. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J. Antimicrob. Chemother. 2005, 55:326-332.
8. Hooper D.C. Emerging mechanisms of fluoroquinolone resistance. Emerg. Infect. Dis. 2001, 7:337-341.
9. Iabadene H., Messai Y., Ammari H., Ramdani-Bouguessa N., Lounes S., Bakour R., Arlet G. Dissemination of ESBL and Qnr determinants in Enterobacter cloacae in Algeria. J. Antimicrob. Chemother. 2008, 62:133-136.
10. Jacoby G., Han P. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J. Clin. Microbiol. 1996, 34:908-911.
11. Jacoby G., Walsh K., Mills D., Walker V., Oh H., Robicsek A., Hooper D. qnrB, another plasmid-mediated gene for quinolone resistance. Antimicrob. Agents Chemother. 2006, 50:1178-1182.
12. Jacoby G., Cattoir V., Hooper D., Martinez-Martinez L., Nordmann P., Pascual A., Poirel L., Wang M. qnr Gene nomenclature. Antimicrob. Agents Chemother. 2008, 52:2297-2299.
13. Kim E.S., Jeong J.Y., Jun J.B., Choi S.H., Lee S.O., Kim M.N., Woo J.H., Kim Y.S. Prevalence of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme among Enterobacteriaceae blood isolates in Korea. Antimicrob. Agents Chemother. 2009.
14. Kim H.B., Park C.H., Kim C.J., Kim E.C., Jacoby G.A., Hooper D.C. Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob. Agents Chemother. 2009, 53:639-645.
15. Martinez-Martinez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
16. McCabe W.R., Jackson G.G. Gram-Negative Bacteremia: I. Etiology and Ecology. Arch. Intern. Med. 1962, 110:847-855.
17. Poirel L., Leviandier C., Nordmann P. Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital. Antimicrob. Agents Chemother. 2006, 50:3992-3997.
18. Poirel L., Pitout J.D., Calvo L., Rodriguez-Martinez J.M., Church D., Nordmann P. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase. Antimicrob. Agents Chemother. 2006, 50:1525-1527.
19. Robicsek A., Sahm D.F., Strahilevitz J., Jacoby G.A., Hooper D.C. Broader distribution of plasmid-mediated quinolone resistance in the United States. Antimicrob. Agents Chemother. 2005, 49:3001-3003.
20. Robicsek A., Strahilevitz J., Sahm D.F., Jacoby G.A., Hooper D.C. qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob. Agents Chemother. 2006, 50:2872-2874.
21. Strahilevitz J., Engelstein D., Adler A., Temper V., Moses A.E., Block C., Robicsek A. Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob. Agents Chemother. 2007, 51:3001-3003.
22. Tamang M.D., Seol S.Y., Oh J.Y., Kang H.Y., Lee J.C., Lee Y.C., Cho D.T., Kim J. Plasmid-mediated quinolone resistance determinants qnrA, qnrB, and qnrS among clinical isolates of Enterobacteriaceae in a Korean hospital. Antimicrob. Agents Chemother. 2008, 52:4159-4162.
23. Wang M., Tran J.H., Jacoby G.A., Zhang Y., Wang F., Hooper D.C. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob. Agents Chemother. 2003, 47:2242-2248.
24. Wu J.J., Ko W.C., Tsai S.H., Yan J.J. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob. Agents Chemother. 2007, 51:1223-1227.
25. Wu J.J., Ko W.C., Wu H.M., Yan J.J. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005. J. Antimicrob. Chemother. 2008, 61:1234-1239.
26. Yang H., Chen H., Yang Q., Chen M., Wang H. High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Antimicrob. Agents Chemother. 2008, 52:4268-4273.